US Patent 7829285 Circulating mRNA as diagnostic markers
Patent 7829285 was granted and assigned to The Chinese University of Hong Kong Chorus on November, 2010 by the United States Patent and Trademark Office.
All edits
Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclampsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.
US Patent 07829285 Circulating mRNA as diagnostic markers US Patent 7829285 Circulating mRNA as diagnostic markers
US Patent 07829285 Circulating mRNA as diagnostic markers
Find more entities like US Patent 7829285 Circulating mRNA as diagnostic markers
